Dyadic International, Inc.

Contributing Author

Recent Articles by Dyadic International, Inc.

Nov-12	Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress DYAI GlobeNewswire
Nov-10	Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics DYAI GlobeNewswire
Oct-29	Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025 DYAI GlobeNewswire
Oct-06	Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments DYAI GlobeNewswire
Sep-04	Dyadic to Present at Investor Conferences and BPI East DYAI GlobeNewswire
Aug-13	Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress DYAI GlobeNewswire
Aug-05	Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025 DYAI GlobeNewswire
Jul-31	UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock DYAI GlobeNewswire
Jul-31	Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock DYAI GlobeNewswire
Jul-30	Dyadic International, Inc. Announces Proposed Public Offering of Common Stock DYAI GlobeNewswire
Jun-02	Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications DYAI GlobeNewswire
May-14	Dyadic Reports First Quarter 2025 Financial Results and Highlights of Recent Company Progress DYAI GlobeNewswire
May-01	Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 DYAI GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.